Capstone Therapeutics retires about 85% of convertible note principal, cuts balance to $1 million
CAPS•Capstone Therapeutics retired about 85% of its original $6.82 million convertible note principal through conversions, reducing outstanding principal to $1 million. The July 2025 note was fully retired, leaving only the October 2025 note outstanding.
1. Convertible notes reduced
Capstone Therapeutics said conversions retired about 85% of the original $6.82 million principal, leaving $1 million outstanding. The July 2025 note has been fully retired; only the October 2025 note remains. Outstanding principal was $1.9 million as of June 30, 2026.
